Posted on 7/21/17
Planet Fitness Expands to Panama
Planet Fitness, Inc. (NYSE: PLNT), one of the largest and fastest-growing franchisors and operators of fitness centers in the U.S., today announced the upcoming opening of . . .
Posted on 7/21/17
Kala Pharmaceuticals Prices IPO
WALTHAM, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (Kala), a biopharmaceutical company focused on the development and commercialization of two Phase 3 product candidates, KPI-121 1.0% for the treatment . . .
Posted on 7/20/17
Novartis Will Hit $100 This Year
There are a lot of moving parts going on in Novartis AG (ADR)(NYSE:NVS) at present, but I still see strong growth coming down the track. The . . .
Posted on 7/20/17
Immunogen Finally Moving 'FORWARD'?
Immunogen (IMGN) is a biotechnology focused on developing antibody drug conjugate (ADC) immunotherapies for improving treatment of cancer. IMGN scientists have specialized expertise in target selection, . . .
Posted on 7/20/17
Akcea Therapeutics Closes IPO
Akcea Therapeutics, Inc. today announced the closing of its initial public offering of 17,968,750 shares common stock at a public offering price of $8.00 per share, . . .
Posted on 7/19/17
Sarepta Therapeutics Secures $100 Million in Debt Financing
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a U.S. commercial-stage biopharmaceutical company focused on the discovery and development of unique
Posted on 7/19/17
PeptiDream and Kleo Pharmaceuticals Announce Collaboration Agreement
PeptiDream Inc., a public Tokyo-based biopharmaceutical company (TOKYO:4587) and Kleo Pharmaceuticals Inc., a New Haven-based company using its proprietary Antibody Recruiting Molecule ("ARM") and Synthetic Antibody . . .
Posted on 7/18/17
Brooks Life Science Systems Announces Expansion of Sample Bioprocessing Laboratory Services at its Indianapolis Biorepository
Brooks Life Science Systems announced today the expansion of its sample preparation and bioprocessing laboratory services at its BioStorage® Technologies center of excellence biorepository in Indianapolis.Brooks' . . .
Posted on 7/18/17
Alzheon Presents Data Related to Lead Candidate ALZ-801 for Alzheimer's on Novel MOA and Long- Term Clinical Efficacy
Presentations Highlight Recent Discovery of Inhibition of Formation of Toxic Beta Amyloid Oligomers and New Insights for Precision Medicine Approach for ALZ-801 Targeting APOE4 CarriersAlzheon, Inc., . . .
Posted on 7/17/17
Better Buy: Biogen Inc. vs. Celgene Corporation
Biogen (NASDAQ:BIIB) and Celgene (NASDAQ:CELG) have ranked among the most successful biotech stocks of the past decade. Biogen stock has soared more than 430% in the . . .
Posted on 7/15/17
Mayo Clinic, nference Launch a Startup
CAMBRIDGE, Mass. & ROCHESTER, Minn.--(BUSINESS WIRE)--Today, Mayo Clinic and nference launch a startup company for drug development that will be powered by clinical expertise and artificial . . .
Posted on 7/14/17
1 Reason Why Cara Therapeutics Ended June Down 11.3%
What happenedCara Therapeutics (NASDAQ:CARA), a clinical-stage biotech developing treatments for pain and chronic kidney disease-associated pruritus (itching), gave investors an absolutely wild ride last month. After . . .
Posted on 7/14/17
How Biogen Inc. Makes Most of Its Money
Biogen (NASDAQ:BIIB) recorded $2.38 billion in product revenue in the first quarter -- a nice haul for a large biotech -- but 40% of its sales . . .
Posted on 7/14/17
Akcea Therapeutics Prices IPO
Akcea Therapeutics, Inc. today announced the pricing of its initial public offering of 15,625,000 shares common stock at a public offering price of $8.00 per share, . . .
Posted on 7/13/17
PuraPly Antimicrobial Named One of Top 10 Innovations in Podiatry
PuraPlyTM Antimicrobial (PuraPlyTM AM), an FDA 510(k)-cleared wound management product from Organogenesis Inc., has been named one of the "Top 10 Innovations in Podiatry" by Podiatry . . .
Posted on 7/13/17
American Health Care Association Recognizes Five Star Senior Living Communities with Three Silver National Quality Awards
NEWTON, Mass.--(BUSINESS WIRE)--Five Star Senior Living (Nasdaq: FVE), one of the nation’s leading senior living and healthcare services providers, is pleased to acknowledge three communities as . . .
Posted on 7/13/17
Sunovion Enters Agreement to Divest Asthma and Allergy Products to Covis Pharma
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) today announced that it has entered into a definitive agreement to divest the U.S. market rights to Sunovion’s ciclesonide products . . .
Posted on 7/13/17
Bionik Laboratories Corp. Completes Offer to Exchange Common Stock for Outstanding Warrants
Bionik Laboratories Corp. (OTCQX:BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, . . .
Posted on 7/13/17
Cambridge BioMarketing Honored with Multiple Industry Recognitions
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cambridge BioMarketing, the world’s leading rare disease and specialty communications agency, today announced that it has been recognized with multiple industry accolades for its . . .
Posted on 7/12/17
Can Cara Therapeutics Stock Bounce Back?
It was only a few weeks ago that Cara Therapeutics (NASDAQ:CARA) stock was hitting all-time highs. The company had announced good news from its independent data . . .
Posted on 7/12/17
MinuteClinic Announces New Partnership to Expand Access to Workplace Health Services
MinuteClinic, the retail medical clinic of CVS Health (NYSE: CVS), today announced that MinuteClinic has joined the Alere eScreen Occupational Health Network (EOHN), a comprehensive alliance . . .
Posted on 7/12/17
InVivo Therapeutics Opens First Site in the United Kingdom for INSPIRE Study
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced that James Cook University Hospital in Middlesbrough, United Kingdom has been added as the UK’s first clinical . . .
Posted on 7/11/17
Biostage Granted Continued Listing on Nasdaq
Biostage, Inc. (Nasdaq: BSTG), a biotechnology company developing bio engineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea, today . . .
Posted on 7/11/17
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, announced that, on July 3, . . .
Posted on 7/11/17
NeuroMetrix Announces $7.0 Million Private Placement of Preferred Stock
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (NASDAQ: NURO) announced today that it has entered into a definitive securities purchase agreement with a healthcare dedicated institutional investor in connection . . .
Boston
